126-02-3

Basic information

• Product Name: cycrimine hydrochloride
• Synonyms: Cycrimine hydrochloride; 1-Phenyl-1-cyclopentyl-3-piperidino-1-propanol hydrochloride; Compound 8958; Cycrimine HCl; Lilly 08958; NSC 169452; Pagitane; Pagitane hydrochloride; UNII-9RB4L4K895; alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol hydrochloride; 1-Piperidinepropanol, alpha-cyclopentyl-alpha-phenyl-, hydrochloride; 1-cyclopentyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride (1:1)
• CAS NO: 126-02-3
• Molecular Formula: C₁₉H₃₀ClNO
• Molecular Weight: 323.9006
• EINECS: 204-764-8
• Mol File: 126-02-3.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 433.5°C at 760 mmHg
• Flash Point: 205.7°C
• Vapor Pressure: 2.76E-08mmHg at 25°C
• CAS DataBase Reference: cycrimine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: cycrimine hydrochloride(126-02-3)
• EPA Substance Registry System: cycrimine hydrochloride(126-02-3)

Safety Data

• Hazardous Substances Data: 126-02-3(Hazardous Substances Data)

Usage

General Description

Cycrimine hydrochloride is a synthetic anticholinergic medication that acts as a muscarinic receptor antagonist. It is used to treat certain gastrointestinal and genitourinary disorders by inhibiting the action of acetylcholine, a neurotransmitter that is involved in the regulation of smooth muscle contraction in the digestive and urinary systems. By blocking the muscarinic receptors, cycrimine hydrochloride helps to reduce the symptoms of conditions such as irritable bowel syndrome, urinary incontinence, and overactive bladder. It can also be used as a preanesthetic medication to reduce secretions in the respiratory tract and prevent nausea and vomiting during surgery. Common side effects of cycrimine hydrochloride include dry mouth, blurred vision, and constipation. This medication is typically taken orally in the form of a tablet or liquid solution.